Accessibility Menu
 
Arcellx logo

Arcellx

(NASDAQ) ACLX

Current Price$114.77
Market Cap$6.71B
Since IPO (2022)+583%
5 YearN/A
1 Year+71%
1 Month+1%

Arcellx Financials at a Glance

Market Cap

$6.71B

Revenue (TTM)

$22.29M

Net Income (TTM)

$228.93M

EPS (TTM)

$-4.05

P/E Ratio

-28.31

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$114.77

Volume

1,212,170

Open

$114.75

Previous Close

$114.77

Daily Range

$114.66 - $114.80

52-Week Range

$47.86 - $114.94

ACLX: Motley Fool Moneyball Superscore

63

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arcellx

Industry

Biotechnology

Employees

209

CEO

Rami Elghandour, MBA

Headquarters

Redwood City, MD 20878, US

ACLX Financials

Key Financial Metrics (TTM)

Gross Margin

-65%

Operating Margin

-11%

Net Income Margin

-10%

Return on Equity

-53%

Return on Capital

-51%

Return on Assets

-38%

Earnings Yield

-3.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.71B

Shares Outstanding

58.48M

Volume

1.21M

Short Interest

0.00%

Avg. Volume

2.23M

Financials (TTM)

Gross Profit

$15.61M

Operating Income

$253.08M

EBITDA

$197.97M

Operating Cash Flow

$210.26M

Capital Expenditure

$2.33M

Free Cash Flow

$212.59M

Cash & ST Invst.

$450.33M

Total Debt

$96.26M

Arcellx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.65M

-89.2%

Gross Profit

$13.00K

-99.9%

Gross Margin

0.79%

N/A

Market Cap

$6.71B

N/A

Market Cap/Employee

$41.18M

N/A

Employees

163

N/A

Net Income

$58.11M

-23.4%

EBITDA

$32.23M

+26.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$354.08M

-33.6%

Accounts Receivable

$3.60M

N/A

Inventory

$0.00

N/A

Long Term Debt

$88.68M

+90.5%

Short Term Debt

$7.58M

+0.6%

Return on Assets

-37.90%

N/A

Return on Invested Capital

-50.64%

N/A

Free Cash Flow

$58.94M

-24.0%

Operating Cash Flow

$58.17M

-26.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTGXProtagonist Therapeutics, Inc.
$103.78+0.11%
KYMRKymera Therapeutics, Inc.
$85.40+0.55%
ALKSAlkermes plc
$34.84-0.60%
PCVXVaxcyte, Inc.
$58.38-0.21%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About ACLX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.